Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 7 November 2008, doi:10.1136/bmj.a2001
Cite this as: BMJ 2008;337:a2001
Lingxia Zeng, researcher/lecturer1, Yue Cheng, PhD candidate1, Shaonong Dang, researcher/lecturer1, Hong Yan, professor/dean1, Michael J Dibley, associate professor, professorial fellow2,3, Suying Chang, associate professor4, Lingzhi Kong, professor5
1 Department of Public Health, Xian Jiaotong University College of Medicine, PO Box 46, Xian, Shaanxi 710061, China, 2 School of Public Health, University of Sydney, Room 307A, Edward Ford Building (A27), University of Sydney, NSW 2006, Australia, 3 George Institute for International Health, PO Box M201, Sydney, NSW 2050, Australia, 4 Chinese Centre for Disease Control and Prevention, Beijing 100050, China, 5 Bureau for Disease Prevention and Control, Ministry of Health, Beijing 100044, China
Correspondence to: H Yan xjtu_yh.paper{at}yahoo.com.cn
Design Cluster randomised double blind controlled trial.
Setting Two rural counties in north west China.
Participants 5828 pregnant women and 4697 live births.
Interventions Villages were randomised for all pregnant women to take either daily folic acid (control), iron with folic acid, or multiple micronutrients with a recommended allowance of 15 vitamins and minerals.
Main outcome measures Birth weight, length, and head circumference measured within 72 hours after delivery. Neonatal survival assessed at the six week follow-up visit.
Results Birth weight was 42 g (95% confidence interval 7 to 78 g) higher in the multiple micronutrients group compared with the folic acid group. Duration of gestation was 0.23 weeks (0.10 to 0.36 weeks) longer in the iron-folic acid group and 0.19 weeks (0.06 to 0.32 weeks) longer in the multiple micronutrients group. Iron-folic acid was associated with a significantly reduced risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031). There was a significant increase in haemoglobin concentration in both iron-folic acid (5.0 g/l, 2.0 to 8.0 g/l, P=0.001) and multiple micronutrients (6.9 g/l, 4.1 to 9.6 g/l, P<0.001) groups compared with folic acid alone. In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).
Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid. Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality. Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.
Trial registration ISRCTN08850194 [controlled-trials.com] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?